SRXH — SRx Health Solutions, Inc.
—
NYSE ·
Consumer Staples ·
Food Products ·
CIK 1471727 ·
Last close
$0.20
Market Cap
$117.76M
52W High
$0.25
52W Low
$0.11
ADV30
57,996,684
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,439,000 | 1,275,000 | -1,818,000 | -6,381,000 | 43,364,000 | 20,543,000 | 25,078,000 |
| Dec 2025 | 2,807,000 | 1,054,000 | -3,790,000 | -8,614,000 | 27,053,000 | 13,060,000 | 23,529,000 |
| Sep 2025 | -34,548,000 | -8,770,000 | 18,081,000 | -15,261,000 | 8,402,000 | 1,309,000 | 7,995,000 |
| Mar 2025 | 7,159,000 | 2,383,000 | -1,088,000 | -964,000 | 15,288,000 | 1,137,000 | 7,324,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,564,000
Investing CF
$-23,995,000
Financing CF
$52,107,000
CapEx
$-8,625,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.45
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-37,923,000
Inventory
$2,086,000
Receivables
$5,213,000
ST Investments
$5,527,000
EBIT TTM
$8,467,000
Pretax Income TTM
$5,785,000
Interest Exp TTM
$3,068,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,780,000
EBITDA
$-15,468,000
Free Cash Flow
—
Enterprise Value
$111,655,408
Total Cash
$26,070,000
Total Debt
$22,616,000
Shares Out
590,254,769
Trailing EPS
$-0.17
Book Value
$0.04
ROE
—
ROA
—
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 6,534,000 | -11,406,000 | -45,006,000 | 8,402,000 | 7,995,000 | — | -8,143,000 |
| Sep 2024 | 0 | 0 | -43,054,000 | 33,764,000 | 88,883,000 | — | -1,478,000 |
TTM Snapshot
Revenues TTM
$28,267,000
NetIncome TTM
$-11,174,000
OpCashFlow TTM
$0
Assets (Latest)
$74,660,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TAP-A | MOLSON COORS BEVERAGE CO | $116.62M | $45.50 | — |
| MED | MEDIFAST INC | $125.09M | $11.25 | — |
| ISPR | Ispire Technology Inc. | $106.76M | $1.86 | — |
| BUDA | BUDA JUICE, INC. | $100.41M | $7.99 | — |
| ZVIA | Zevia PBC | $92.59M | $1.29 | — |
News headlines (Yahoo Finance, 1h cache)
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision
2026-05-21 17:42 · Yahoo
Why Is Opendoor (OPEN) Stock Rocketing Higher Today
2026-04-17 03:54 · Yahoo
SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine
2026-04-07 13:05 · Yahoo
SRx Health Solutions Launches EventHorizonIQ Subscription for Individual and Institutional Traders
2026-03-09 12:30 · Yahoo
SRx Health Solutions Announces Receipt of Warning Letter from NYSE American
2026-02-20 13:00 · Yahoo
SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Sh
2026-02-11 13:00 · Yahoo
Crypto Currents: Strategy, Galaxy Digital report Q4 earnings results
2026-02-07 15:30 · Yahoo
A Look At Opendoor Technologies (OPEN) Valuation As New Stake And Policy Support Refocus Investor Attention
2026-01-23 12:12 · Yahoo
How Investors Are Reacting To Opendoor Technologies (OPEN) After SRx Stake And CEO’s Housing Policy Support
2026-01-23 04:37 · Yahoo
SRx Health Solutions Invests in Common Stock of Opendoor Technologies
2026-01-16 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.